RadNet, Inc. Stock

Equities

RDNT

US7504911022

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-05-17 pm EDT 5-day change 1st Jan Change
57.45 USD -0.23% Intraday chart for RadNet, Inc. +3.98% +65.23%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 1.77B Sales 2025 * 1.92B Capitalization 4.24B
Net income 2024 * 35M Net income 2025 * 57M EV / Sales 2024 * 2.4 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.22 x
P/E ratio 2024 *
122 x
P/E ratio 2025 *
74.1 x
Employees 8,157
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.59%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.23%
1 week+3.98%
Current month+18.45%
1 month+20.19%
3 months+50.04%
6 months+79.03%
Current year+65.23%
More quotes
1 week
54.16
Extreme 54.16
58.59
1 month
46.18
Extreme 46.18
58.59
Current year
33.44
Extreme 33.44
58.59
1 year
25.11
Extreme 25.11
58.59
3 years
12.03
Extreme 12.03
58.59
5 years
5.81
Extreme 5.81
58.59
10 years
4.66
Extreme 4.66
58.59
More quotes
Managers TitleAgeSince
Chief Executive Officer 79 79-12-31
Director of Finance/CFO 52 04-02-29
Chief Tech/Sci/R&D Officer 66 14-12-31
Members of the board TitleAgeSince
Director of Finance/CFO 52 04-02-29
Director/Board Member 80 03-12-31
Director/Board Member 81 04-12-31
More insiders
Date Price Change Volume
24-05-17 57.45 -0.23% 303,107
24-05-16 57.58 -1.13% 380,199
24-05-15 58.24 +2.66% 360,391
24-05-14 56.73 +1.81% 355,778
24-05-13 55.72 +0.85% 549,234

Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT

More quotes
RadNet, Inc. is a national provider of fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States. It has a network of 366 owned and/or operated outpatient imaging centers. The Company’s Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company’s Artificial Intelligence (AI) segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. The Company, through its joint ventured Arizona Diagnostic Radiology Group, LLC, owns seven outpatient imaging centers.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
57.45 USD
Average target price
57.17 USD
Spread / Average Target
-0.49%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW